Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-11 | Suzanne Gagnon, M.D., has served as our Chief Medical Officer and as a director of our Company since the effective time of the Merger. |
| 2017-04-27 | Suzanne Gagnon, M.D., has served as our Chief Medical Officer and as a director of our Company since September 4, 2015. Dr. Gagnon had previously served as a director of Sun BioPharma Research, Inc. ("SBR"), a former affiliate of the Company, since June 2015 and as its Chief Medical Officer since January 2015. Directors who are also our employees receive no additional compensation for serving on our Board of Directors. |
| 2017-08-22 | Executive Officers and Directors Suzanne Gagnon 911,250 Includes 10,000 shares held by the Gagnon Family Trust, 456,250 shares subject to stock options and 15,000 shares subject to warrants. |
| 2018-04-16 | Suzanne Gagnon, M.D., has served as our Chief Medical Officer and as a director of our Company since September 4, 2015... During 2016 and 2017, Dr. Gagnon received compensation from the Company amounting to $177,000 and $195,000, respectively. |
| 2019-04-16 | Suzanne Gagnon, M.D., Chief Medical Officer and Director. Age 62. Compensation in 2018 was $207,700. No committee memberships listed. |
| 2020-04-20 | Suzanne Gagnon, M.D., has served as our Chief Medical Officer and as a director of our Company since September 2015. |
| 2021-04-15 | Suzanne Gagnon, M.D., has served as our Chief Medical Officer and as a director of our Company since June 2015 and as its Chief Medical Officer since January 2015. |
| 2022-04-29 | Suzanne Gagnon 65 Director |
Data sourced from SEC filings. Last updated: 2026-03-05